about
Automatic evaluation of progression angle and fetal head station through intrapartum echographic monitoring.Bladeless direct optical trocar insertion in laparoscopic procedures on the obese patient.Laparoscopic, minilaparoscopic, single-port and percutaneous hysterectomy: Comparison of perioperative outcomes of minimally invasive approaches in gynecologic surgery.The Senhance™ surgical robotic system ("Senhance") for total hysterectomy in obese patients: a pilot study.Needleoscopic Conservative Staging of Borderline Ovarian Tumor.Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study.The surgical outcome of intracapsular cesarean myomectomy. A match control study.Role of blue dye for sentinel lymph node detection in early endometrial cancer.Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery vs Standard Laparotomic Treatment: From Body to Mind and Back.3 mm Senhance robotic hysterectomy: a step towards future perspectives.Total Laparoscopic (S-LPS) versus TELELAP ALF-X Robotic-Assisted Hysterectomy: A Case-Control Study.Laparoscopic vs. Transvaginal Cuff Closure After Total Laparoscopic Hysterectomy: A Randomized Trial by the Italian Society of Gynecologic Endoscopy.Laparoscopic Pelvic Exenteration With Radical Vaginectomy Using 3-Dimensional Vision and Multifunction InstrumentRobotic video endoscopic inguinal lymphadenectomy (R-VEIL) for vulvar cancer with sentinel node mapping using indocyanine green and near-infrared fluorescence imaging technologyTreatment of gynecological disease in obese patient: which role for telelap ALF-X platform?ReplyPI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancersInguino-abdominal combined approach for laterally extended pelvic resection: a step by step procedureTechnological innovation and personalized surgical treatment for early-stage endometrial cancer patients: A prospective multicenter Italian experience to evaluate the novel percutaneous approachSacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivoFeasibility and perioperative outcomes of percutaneous-assisted laparoscopic hysterectomy: A multicentric Italian experiencePARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparibSexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire
P50
Q37196765-38FDADAD-D9A3-45BD-AF37-05E5CB649895Q37399144-1EE640DF-2D1B-44B2-9D66-83C7D3FDF224Q38655333-F90EACDD-97AB-4CFE-B300-C9F7B3E639AAQ38720767-144FE85C-EA47-4963-BEF2-606F9BD7C394Q39042763-7D7571A6-5F91-47F9-B738-110E475A6D64Q40180770-D077319D-2340-4ED8-AB67-E1E12047C749Q43585528-00FB56CE-682C-4C96-AD47-BC1CFF103361Q47096757-6E0365A1-7079-4515-821F-791BD7C943F2Q47264460-591E4F17-6EEE-470D-A341-6139BFA0FD37Q47715686-89B169DF-D3B4-4446-B3C3-93ABCF6226D4Q47781946-5F211B4C-6B58-4B15-B46A-AA2FA8AC5B51Q50057670-DFD984AD-F36E-4479-8FFE-F40105FB5738Q57791762-52FF2A86-C077-4471-AB18-E647BAA04969Q88578263-8932CD17-8BE4-4FA7-95BE-D8ABCDE672C3Q89218621-DCF9681A-588C-4472-B048-40E8DEA89C73Q89256527-AD53ABF6-7778-4F7B-A468-D414DE336B35Q90987627-A6D46859-545D-42B3-A99D-4C43CE62D647Q91339740-5B7B2AEC-FC0C-4573-BF82-7C6F11395075Q91400533-3F176BCC-2386-487A-80D9-38C9AF842CC8Q92350174-714E3C3D-5F2E-4736-8A28-B4DDFDBABC2FQ92556963-E91F55D4-9562-494B-A714-7B253F6C1A12Q92755253-F9A18D34-FB69-4BA9-97AC-73649A973957Q92879613-0AE44EBC-77DA-4ACF-ADCC-CB9750750440
P50
description
researcher ORCID ID = 0000-0002-0938-2493
@en
wetenschapper
@nl
name
Emanuele Perrone
@ast
Emanuele Perrone
@en
Emanuele Perrone
@es
Emanuele Perrone
@nl
type
label
Emanuele Perrone
@ast
Emanuele Perrone
@en
Emanuele Perrone
@es
Emanuele Perrone
@nl
prefLabel
Emanuele Perrone
@ast
Emanuele Perrone
@en
Emanuele Perrone
@es
Emanuele Perrone
@nl
P31
P496
0000-0002-0938-2493